Introduction: Ovarian cancer is one of the three most common gynecological cancers, with the highest mortality rate among gynecological malignancies. Previous studies on the environmental and socioeconomic (ESE) factors that affect ovarian cancer incidence (OCI) have generally only considered the net effects of single variables, while the synergistic effects among multiple factors have yet to be explored.

Methods: Based on a sample of 30 provinces in Mainland China, an ESE configuration model was constructed in this study, using a fuzzy-set qualitative comparative analysis approach to empirically explore the configuration effects of multiple ESE factors on OCI.

Results: (1) Education, marriage, income, insurance, urbanization, and environment alone do not constitute the necessary conditions for high or low OCI, indicating a need to comprehensively consider the configuration effects of these six conditions. (2) There are two configurations for high OCI: "configuration of environmental pollution under low socioeconomic development" and "configuration of insurance deficiency under high socioeconomic development." (3) There are two configurations for low OCI: "configuration of insurance adequacy under low socioeconomic development" and "configuration of insurance adequacy under low urbanization."

Conclusion: The main contribution of this study is its focus on the configuration mechanism of ESE factors, enhancing understanding of the synergistic effects among the multiple factors that affect OCI. The study also provides valuable policy implications for decision-makers to formulate comprehensive health policies for the prevention and treatment of ovarian cancer.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11617518PMC
http://dx.doi.org/10.3389/fpubh.2024.1405010DOI Listing

Publication Analysis

Top Keywords

ovarian cancer
16
ese factors
12
effects multiple
12
socioeconomic development"
12
"configuration insurance
12
cancer incidence
8
policy implications
8
fuzzy-set qualitative
8
qualitative comparative
8
comparative analysis
8

Similar Publications

Ovarian cancer (OC) must be detected in its early stages when the mortality rate is the lowest to provide patients with the best chance of survival. Lysophosphatidic acid (LPA) is a critical OC biomarker since its levels are elevated across all stages and increase with disease progression. This paper presents an LPA assay based on a thickness shear mode acoustic sensor with dissipation monitoring that involves a new thiol molecule 3-(2-mercaptoethanoxy)propanoic acid (HS-MEG-COOH).

View Article and Find Full Text PDF

: Pathophysiological variability in patients with cancer is associated with differences in responses to pharmacotherapy. In this work, we aimed to describe the demographic characteristics and hematological, biochemical, and coagulation variables in a large oncology cohort and to develop, optimize, and provide open access to modeling equations for the estimation of variables potentially relevant in pharmacokinetic modeling. : Using data from 1793 patients with cancer, divided into training ( = 1259) and validation ( = 534) datasets, a modeling network was developed and used to simulate virtual oncology populations.

View Article and Find Full Text PDF

Ovarian cancer is the deadliest gynecologic cancer, and with the majority of patients dying within the first five years of diagnosis, new therapeutic options are required. The small guanosine triphosphatase (GTPase) Ras-related nuclear protein (Ran) has been reported to be highly expressed in high-grade serous ovarian cancers (HGSOCs) and associated with poor outcomes. Blocking Ran function or preventing its expression were shown to be promising treatment strategies, however, there are currently no small molecule inhibitors available to specifically inhibit Ran function.

View Article and Find Full Text PDF

Ovarian cancer has the highest mortality rate in the world. Treatment methods are listed as surgery, chemotherapy, and radiotherapy, depending on the stage of cancer, but developing resistance to chemotherapy increases the need for alternative agents that act on the same pathways. The effects of rosmarinic acid (RA) and doxorubicin (DX) on the activation of FOXP3, an important tumor suppressor gene, in OVCAR3 cells were examined.

View Article and Find Full Text PDF

The aim of this study was to determine the effect of Sparstolonin B (SsnB) on cell proliferation and apoptosis in human breast cancer (MCF-7) and human ovarian epithelial cancer (OVCAR-3) cell lines in the presence and absence of estradiol hemihydrate (ES). Phosphoinositol-3 kinase (PI3K), phosphorylated protein kinase B alpha (p-AKT), phosphorylated mTOR (mechanistic target of rapamycin) signaling proteins, and sphingomyelin/ceramide metabolites were also measured within the scope of the study. The anti-proliferative effects of SsnB therapy were evaluated over a range of times and concentrations.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!